Organogenesis Holdings (ORGO) Cash & Equivalents (QoQ) (2016 - 2026)
Organogenesis Holdings (ORGO) Cash & Equivalents (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.46% |
| Dec 31, 2025 | 46.96% |
| Sep 30, 2025 | -12.77% |
| Jun 30, 2025 | -33.55% |
| Mar 31, 2025 | -18.89% |
| Dec 31, 2024 | 43.70% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | 1.44% |
| Mar 31, 2024 | -14.65% |
| Dec 31, 2023 | 5.72% |
| Sep 30, 2023 | 10.47% |
| Jun 30, 2023 | 0.25% |
| Mar 31, 2023 | -13.45% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | -4.48% |
| Jun 30, 2022 | 4.06% |
| Mar 31, 2022 | -5.29% |
| Sep 30, 2018 | 0.46% |
| Jun 30, 2018 | 316,324.88% |
| Mar 31, 2018 | -20.97% |